EMA/PE/0000233797

EMA/PE/0000189672

Opinion/decision on a Paediatric investigation plan (PIP): Lupkynis, voclosporin, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Musculoskeletal and connective tissue disorders, PIP number: P/0152/2019

Opinion/decision on a Paediatric investigation plan (PIP): Vyvgart, efgartigimod alfa, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Nervous system disorders, PIP number: P/0298/2024

Orphan designation: 1-Deoxygalactonojirimycin hydrochloride Treatment of Fabry disease, 22/05/2006 Expired

EMA/PE/0000232890

How to recognise scams and phishing using EMA credentials

Opinion/decision on a Paediatric investigation plan (PIP): Sotyktu, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0008/2024

Opinion/decision on a Paediatric investigation plan (PIP): Stelara, ustekinumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastrointestinal disorders, PIP number: P/0084/2021

EMA/PE/0000227963